Dimension is a venture capital firm that prefers to invest in biotech,life science, software, infrastructure, lab tools and instruments, clinical development, manufacturing commercialization, machine learning, and artificial intelligence industries.
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.